By expenditures
| Name | Title | Type |
|---|---|---|
| Kimberly Meck | Executive Director | Auditee |
| Bryce Rassilyer | Principal | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 319773 | 2022 | 2024-09-17 | Cliftonlarsonallen LLP | $1.04M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 319773 | 2022 | 2024-09-17 | 1073510 | 2022-007 | Material Weakness | - | AB |
| 319773 | 2022 | 2024-09-17 | 1073509 | 2022-006 | Significant Deficiency | - | AB |
| 319773 | 2022 | 2024-09-17 | 1073508 | 2022-005 | Material Weakness | - | C |
| 319773 | 2022 | 2024-09-17 | 1073507 | 2022-004 | Material Weakness | - | M |
| 319773 | 2022 | 2024-09-17 | 1073506 | 2022-007 | Material Weakness | - | AB |
| 319773 | 2022 | 2024-09-17 | 1073505 | 2022-006 | Significant Deficiency | - | AB |
| 319773 | 2022 | 2024-09-17 | 1073504 | 2022-005 | Material Weakness | - | C |
| 319773 | 2022 | 2024-09-17 | 1073503 | 2022-004 | Material Weakness | - | M |
| 319773 | 2022 | 2024-09-17 | 1073502 | 2022-007 | Material Weakness | - | AB |
| 319773 | 2022 | 2024-09-17 | 1073501 | 2022-006 | Significant Deficiency | - | AB |
| 319773 | 2022 | 2024-09-17 | 1073500 | 2022-005 | Material Weakness | - | C |
| 319773 | 2022 | 2024-09-17 | 1073499 | 2022-004 | Material Weakness | - | M |
| 319773 | 2022 | 2024-09-17 | 1073498 | 2022-007 | Material Weakness | - | AB |
| 319773 | 2022 | 2024-09-17 | 1073497 | 2022-006 | Significant Deficiency | - | AB |
| 319773 | 2022 | 2024-09-17 | 1073496 | 2022-005 | Material Weakness | - | C |
| 319773 | 2022 | 2024-09-17 | 1073495 | 2022-004 | Material Weakness | - | M |
| 319773 | 2022 | 2024-09-17 | 497068 | 2022-007 | Material Weakness | - | AB |
| 319773 | 2022 | 2024-09-17 | 497067 | 2022-006 | Significant Deficiency | - | AB |
| 319773 | 2022 | 2024-09-17 | 497066 | 2022-005 | Material Weakness | - | C |
| 319773 | 2022 | 2024-09-17 | 497065 | 2022-004 | Material Weakness | - | M |
| 319773 | 2022 | 2024-09-17 | 497064 | 2022-007 | Material Weakness | - | AB |
| 319773 | 2022 | 2024-09-17 | 497063 | 2022-006 | Significant Deficiency | - | AB |
| 319773 | 2022 | 2024-09-17 | 497062 | 2022-005 | Material Weakness | - | C |
| 319773 | 2022 | 2024-09-17 | 497061 | 2022-004 | Material Weakness | - | M |
| 319773 | 2022 | 2024-09-17 | 497060 | 2022-007 | Material Weakness | - | AB |
| 319773 | 2022 | 2024-09-17 | 497059 | 2022-006 | Significant Deficiency | - | AB |
| 319773 | 2022 | 2024-09-17 | 497058 | 2022-005 | Material Weakness | - | C |
| 319773 | 2022 | 2024-09-17 | 497057 | 2022-004 | Material Weakness | - | M |
| 319773 | 2022 | 2024-09-17 | 497056 | 2022-007 | Material Weakness | - | AB |
| 319773 | 2022 | 2024-09-17 | 497055 | 2022-006 | Significant Deficiency | - | AB |
| 319773 | 2022 | 2024-09-17 | 497054 | 2022-005 | Material Weakness | - | C |
| 319773 | 2022 | 2024-09-17 | 497053 | 2022-004 | Material Weakness | - | M |